MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$59,789K
(-41.36%↓ Y/Y)
Unrealized gain on
marketable securities
$189K
(610.81%↑ Y/Y)
Interest income
$8,246K
(-7.40%↓ Y/Y)
Net loss
-$59,978K
(-41.93%↓ Y/Y)
Total other income,
net
$8,081K
(-6.43%↓ Y/Y)
Other expense, net
-$165K
(-1.23%↓ Y/Y)
Loss from operations
-$68,059K
(-33.73%↓ Y/Y)
Total operating
expenses
$68,059K
(33.73%↑ Y/Y)
Research and development
$51,522K
(34.10%↑ Y/Y)
General and
administrative
$16,537K
(32.59%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM)